TYP 8.11% 2.0¢ tryptamine therapeutics limited

Ann: Exopharm Gains US Patent for LEAP Technology, page-7

  1. 1,366 Posts.
    lightbulb Created with Sketch. 280
    My issue isn't with the delays, it's with Dixon telling shareholders that a deal is around the corner and no further CRs would be required. I don't mind enthusiasm but I also want realistic timelines and market updates without any fluff. Until I see a deal penned down on paper, I'll sit out just in case another surprise CR comes out of the woodwork due to delays or whatever else.
    GLTAH
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.002(8.11%)
Mkt cap ! $21.78M
Open High Low Value Volume
1.9¢ 2.0¢ 1.9¢ $57.60K 2.928M

Buyers (Bids)

No. Vol. Price($)
4 1076509 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 277183 2
View Market Depth
Last trade - 16.10pm 10/07/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.